CXCR3 ameliorates neutrophil-dependent disease severity in SARS-CoV-2 infection by regulating CD4+ T cell recruitment

Uddin et al., Frontiers in Immunology, doi:10.3389/fimmu.2026.1823264, Jun 2026
Mouse study showing that CXCR3 signaling is protective against SARS-CoV-2 infection, with CXCR3 blockade increasing disease severity in C57BL/6 mice infected with mouse-adapted SARS-CoV-2 (MA-10).
Uddin et al., 11 Jun 2026, peer-reviewed, 8 authors. Contact: wap3g@virginia.edu.
Abstract: OPEN ACCESS EDITED BY Laura Fantuzzi, National Institute of Health (ISS), Italy REVIEWED BY Shamik Majumdar, National Institute of Allergy and Infectious Diseases (NIH), United States Latifa Zayou, University of California, Irvine, United States *CORRESPONDENCE William A. Petri Jr. [wap3g@virginia.edu](mailto:wap3g@virginia.edu) RECEIVED 04 March 2026 REVISED 15 May 2026 ACCEPTED 29 May 2026 PUBLISHED 11 June 2026 CITATION Uddin MJ, Fleming C, Natale NR, Hart D, Moreau B, Day A, Allen J and Petri Jr. WA (2026) CXCR3 ameliorates neutrophil-dependent disease severity in SARS-CoV-2 infection by regulating CD4 + T cell recruitment. Front. Immunol. 17:1823264. [doi: 10.3389/fimmu.2026.1823264](https://doi.org/10.3389/fimmu.2026.1823264) COPYRIGHT © 2026 Uddin, Fleming, Natale, Hart, Moreau, Day, Allen and Petri. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. [CXCR3 ameliorates neutrophildependent disease severity in SARS-CoV-2 infection by regulating CD4 + T cell recruitment](https://www.frontiersin.org/articles/10.3389/fimmu.2026.1823264/full) Md Jashim Uddin 1,2 , Claire Fleming 1,3 , Nick R. Natale 1,4 , Duncan Hart 1,3 , Brett Moreau 1 , Anthony Day 5,6 , Judith Allen 5,6 and William A. Petri Jr. 1,3,4,7 * 1 Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, VA, United States, 2 Henry M Jackson Foundation for the Advancement of Military Medicine, Bethesda, VA, United States, 3 Department of Microbiology, Immunology and Cancer Biology, School of Medicine, University of Virginia, Charlottesville, VA, United States, 4 Neuroscience Graduate Program, University of Virginia, Charlottesville, VA, United States, 5 Lydia Becker Institute of Immunology and In fl ammation, School of Biological Sciences, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom, 6 Wellcome Trust Centre for Cell-Matrix Research, School of Biological Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom, 7 Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA, United States Understanding the host immune response to SARS-CoV-2 infection is critical for developing effective immunotherapeutic interventions. Using bulk RNA sequencing of lung tissue from mock-infected and mouse-adapted SARS-CoV-2 strain MA-10-infected mice, we identi fi ed CXCL9, CXCL10, and CXCL11 as among the most upregulated transcripts. Notably, their shared receptor, CXCR3, was also upregulated, suggesting activation of the CXCL9/10/11-CXCR3 axis in the lungs. Using spectral fl ow cytometry, we observed that the increased recruitment of CXCR3 + immune cells, particularly T cells, innate lymphoid cells (ILCs), and macrophages, correlated with milder disease outcome. Blocking CXCR3 signaling using monoclonal antibodies resulted in worsened disease, which was accompanied by reduced recruitment of T cells, ILCs, and macrophages, and a marked..
DOI record: { "DOI": "10.3389/fimmu.2026.1823264", "ISSN": [ "1664-3224" ], "URL": "http://dx.doi.org/10.3389/fimmu.2026.1823264", "abstract": "<jats:p>\n Understanding the host immune response to SARS-CoV-2 infection is critical for developing effective immunotherapeutic interventions. Using bulk RNA sequencing of lung tissue from mock-infected and mouse-adapted SARS-CoV-2 strain MA-10-infected mice, we identified CXCL9, CXCL10, and CXCL11 as among the most upregulated transcripts. Notably, their shared receptor, CXCR3, was also upregulated, suggesting activation of the CXCL9/10/11-CXCR3 axis in the lungs. Using spectral flow cytometry, we observed that the increased recruitment of CXCR3\n <jats:sup>+</jats:sup>\n immune cells, particularly T cells, innate lymphoid cells (ILCs), and macrophages, correlated with milder disease outcome. Blocking CXCR3 signaling using monoclonal antibodies resulted in worsened disease, which was accompanied by reduced recruitment of T cells, ILCs, and macrophages, and a marked increase in neutrophil infiltration. Depletion of neutrophils using αLy6G antibodies in CXCR3-blocked mice alleviated disease severity, indicating that CXCR3 signaling mitigated neutrophil-driven pathology. CXCR3 blockade failed to exacerbate disease in RAG2\n <jats:sup>-/-</jats:sup>\n mice, suggesting that CXCR3-mediated protection requires adaptive immune cells. Adoptive transfer of CD4\n <jats:sup>+</jats:sup>\n T cells from wild type (WT), but not CXCR3\n <jats:sup>-/-</jats:sup>\n , mice conferred protection in RAG2\n <jats:sup>-/-</jats:sup>\n mice. Together, our findings establish a protective role for CXCR3-recruited T cells blocking neutrophil infiltration in the lung, highlighting the mechanistic importance of the CXCL9/10/11-CXCR3 axis in protecting the lung from SARS-CoV-2 infection.\n </jats:p>", "alternative-id": [ "10.3389/fimmu.2026.1823264" ], "article-number": "1823264", "author": [ { "affiliation": [ { "name": "Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System", "place": [ "Charlottesville, VA, United States" ] }, { "name": "Henry M Jackson Foundation for the Advancement of Military Medicine", "place": [ "Bethesda, VA, United States" ] } ], "family": "Uddin", "given": "Md Jashim", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "first" }, { "affiliation": [ { "name": "Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System", "place": [ "Charlottesville, VA, United States" ] }, { "name": "Department of Microbiology, Immunology and Cancer Biology, School of Medicine, University of Virginia", "place": [ "Charlottesville, VA, United States" ] } ], "family": "Fleming", "given": "Claire", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System", "place": [ "Charlottesville, VA, United States" ] }, { "name": "Neuroscience Graduate Program, University of Virginia", "place": [ "Charlottesville, VA, United States" ] } ], "family": "Natale", "given": "Nick R.", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System", "place": [ "Charlottesville, VA, United States" ] }, { "name": "Department of Microbiology, Immunology and Cancer Biology, School of Medicine, University of Virginia", "place": [ "Charlottesville, VA, United States" ] } ], "family": "Hart", "given": "Duncan", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System", "place": [ "Charlottesville, VA, United States" ] } ], "family": "Moreau", "given": "Brett", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "Lydia Becker Institute of Immunology and Inflammation, School of Biological Sciences, University of Manchester, Manchester Academic Health Sciences Centre", "place": [ "Manchester, United Kingdom" ] }, { "name": "Wellcome Trust Centre for Cell-Matrix Research, School of Biological Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre", "place": [ "Manchester, United Kingdom" ] } ], "family": "Day", "given": "Anthony", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "Lydia Becker Institute of Immunology and Inflammation, School of Biological Sciences, University of Manchester, Manchester Academic Health Sciences Centre", "place": [ "Manchester, United Kingdom" ] }, { "name": "Wellcome Trust Centre for Cell-Matrix Research, School of Biological Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre", "place": [ "Manchester, United Kingdom" ] } ], "family": "Allen", "given": "Judith", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System", "place": [ "Charlottesville, VA, United States" ] }, { "name": "Department of Microbiology, Immunology and Cancer Biology, School of Medicine, University of Virginia", "place": [ "Charlottesville, VA, United States" ] }, { "name": "Neuroscience Graduate Program, University of Virginia", "place": [ "Charlottesville, VA, United States" ] }, { "name": "Department of Pathology, University of Virginia School of Medicine", "place": [ "Charlottesville, VA, United States" ] } ], "family": "Petri", "given": "William A.", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional", "suffix": "Jr." } ], "container-title": "Frontiers in Immunology", "container-title-short": "Front. Immunol.", "content-domain": { "crossmark-restriction": true, "domain": [ "frontiersin.org" ] }, "created": { "date-parts": [ [ 2026, 6, 11 ] ], "date-time": "2026-06-11T05:46:52Z", "timestamp": 1781156812000 }, "deposited": { "date-parts": [ [ 2026, 6, 11 ] ], "date-time": "2026-06-11T05:46:53Z", "timestamp": 1781156813000 }, "indexed": { "date-parts": [ [ 2026, 6, 11 ] ], "date-time": "2026-06-11T06:01:10Z", "timestamp": 1781157670141, "version": "3.54.1" }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2026, 6, 11 ] ] }, "license": [ { "URL": "https://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2026, 6, 11 ] ], "date-time": "2026-06-11T00:00:00Z", "timestamp": 1781136000000 } } ], "link": [ { "URL": "https://www.frontiersin.org/articles/10.3389/fimmu.2026.1823264/full", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "1965", "original-title": [], "prefix": "10.3389", "published": { "date-parts": [ [ 2026, 6, 11 ] ] }, "published-online": { "date-parts": [ [ 2026, 6, 11 ] ] }, "publisher": "Frontiers Media SA", "reference": [ { "DOI": "10.1007/s12223-025-01299-9", "article-title": "Comprehensive global-scale evaluation of the COVID-19 pandemic associated with 234 countries, territories, and sub-national locations during 2020–2024", "author": "Chakraborty", "doi-asserted-by": "publisher", "journal-title": "Folia Microbiol", "key": "B1", "year": "2025" }, { "DOI": "10.1016/S2213-2600(20)30316-7", "article-title": "Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study", "author": "Karagiannidis", "doi-asserted-by": "publisher", "journal-title": "Lancet Respir Med", "key": "B2", "volume": "8", "year": "2020" }, { "DOI": "10.1038/s41586-020-2521-4", "article-title": "Factors associated with COVID-19-related death using OpenSAFELY", "author": "Williamson", "doi-asserted-by": "publisher", "journal-title": "Nature", "key": "B3", "volume": "584", "year": "2020" }, { "DOI": "10.1016/S1473-3099(21)00703-9", "article-title": "A clinical case definition of post-COVID-19 condition by a Delphi consensus", "author": "Soriano", "doi-asserted-by": "publisher", "journal-title": "Lancet Infect Dis", "key": "B4", "volume": "22", "year": "2022" }, { "DOI": "10.1016/S0140-6736(20)30183-5", "article-title": "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China", "author": "Huang", "doi-asserted-by": "publisher", "first-page": "497", "journal-title": "Lancet", "key": "B5", "volume": "395", "year": "2020" }, { "DOI": "10.1038/s41423-021-00665-0", "article-title": "Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm", "author": "Zhang", "doi-asserted-by": "publisher", "journal-title": "Cell Mol Immunol", "key": "B6", "volume": "18", "year": "2021" }, { "DOI": "10.1172/jci.insight.150107", "article-title": "IL-13 is a driver of COVID-19 severity", "author": "Donlan", "doi-asserted-by": "publisher", "journal-title": "JCI Insight", "key": "B7", "volume": "6", "year": "2021" }, { "DOI": "10.1126/sciimmunol.abd2071", "article-title": "Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome", "author": "Weiskopf", "doi-asserted-by": "publisher", "journal-title": "Sci Immunol", "key": "B8", "volume": "5", "year": "2020" }, { "DOI": "10.1056/NEJMoa2031994", "article-title": "Baricitinib plus remdesivir for hospitalized adults with covid-19", "author": "Kalil", "doi-asserted-by": "publisher", "first-page": "795", "journal-title": "N Engl J Med", "key": "B9", "volume": "384", "year": "2021" }, { "DOI": "10.1093/ofid/ofac343", "article-title": "Safety and efficacy of dupilumab for the treatment of hospitalized patients with moderate to severe coronavirus disease 2019: A phase 2a trial", "author": "Sasson", "doi-asserted-by": "publisher", "journal-title": "Open Forum Infect Dis", "key": "B10", "volume": "9", "year": "2022" }, { "DOI": "10.1007/s12026-008-8049-6", "article-title": "Neutrophil apoptosis and the resolution of infection", "author": "Kennedy", "doi-asserted-by": "publisher", "first-page": "25", "journal-title": "Immunol Res", "key": "B11", "volume": "43", "year": "2009" }, { "DOI": "10.1152/physrev.00012.2018", "article-title": "The neutrophil’s role during health and disease", "author": "Liew", "doi-asserted-by": "publisher", "journal-title": "Physiol Rev", "key": "B12", "volume": "99", "year": "2019" }, { "DOI": "10.1038/s41392-024-02049-y", "article-title": "Neutrophil diversity and function in health and disease", "author": "Zhang", "doi-asserted-by": "publisher", "journal-title": "Sig Transduct Target Ther", "key": "B13", "volume": "9", "year": "2024" }, { "DOI": "10.1038/s41467-024-55272-0", "article-title": "Neutrophil adhesion to vessel walls impairs pulmonary circulation in COVID-19 pathology", "author": "Ueki", "doi-asserted-by": "publisher", "journal-title": "Nat Commun", "key": "B14", "volume": "16", "year": "2025" }, { "DOI": "10.1126/scitranslmed.adn7527", "article-title": "SARS-CoV-2 induces neutrophil degranulation and differentiation into myeloid-derived suppressor cells associated with severe COVID-19", "author": "Hsieh", "doi-asserted-by": "publisher", "journal-title": "Sci Transl Med", "key": "B15", "volume": "17", "year": "2025" }, { "DOI": "10.1084/jem.20201129", "article-title": "SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology", "author": "Veras", "doi-asserted-by": "publisher", "journal-title": "J Exp Med", "key": "B16", "volume": "217", "year": "2020" }, { "DOI": "10.4049/jimmunol.0804119", "article-title": "Lymphocytes in the development of lung inflammation: A role for regulatory CD4+ T cells in indirect pulmonary lung injury", "author": "Venet", "doi-asserted-by": "publisher", "journal-title": "J Immunol", "key": "B17", "volume": "183", "year": "2009" }, { "DOI": "10.1038/icb.2010.158", "article-title": "CXCR3 ligands: redundant, collaborative and antagonistic functions", "author": "Groom", "doi-asserted-by": "publisher", "journal-title": "Immunol Cell Biol", "key": "B18", "volume": "89", "year": "2011" }, { "DOI": "10.1038/s41594-023-01175-5", "article-title": "Structural insights into the activation and inhibition of CXC chemokine receptor 3", "author": "Jiao", "doi-asserted-by": "publisher", "journal-title": "Nat Struct Mol Biol", "key": "B19", "volume": "31", "year": "2024" }, { "DOI": "10.3390/v14112445", "article-title": "CXCL10 chemokine: A critical player in RNA and DNA viral infections", "author": "Elemam", "doi-asserted-by": "publisher", "journal-title": "Viruses", "key": "B20", "volume": "14", "year": "2022" }, { "DOI": "10.1002/eji.200838155", "article-title": "CXCL10/CXCR3‐mediated responses promote immunity to respiratory syncytial virus infection by augmenting dendritic cell and CD8+ T cell efficacy", "author": "Lindell", "doi-asserted-by": "publisher", "journal-title": "Eur J Immunol", "key": "B21", "volume": "38", "year": "2008" }, { "DOI": "10.1186/s13073-021-00881-3", "article-title": "IFN-γ and TNF-α drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation", "author": "Zhang", "doi-asserted-by": "publisher", "first-page": "64", "journal-title": "Genome Med", "key": "B22", "volume": "13", "year": "2021" }, { "DOI": "10.1038/s41586-020-2708-8", "article-title": "A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures", "author": "Dinnon", "doi-asserted-by": "publisher", "journal-title": "Nature", "key": "B23", "volume": "586", "year": "2020" }, { "DOI": "10.1074/jbc.273.29.18288", "article-title": "Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors", "author": "Weng", "doi-asserted-by": "publisher", "journal-title": "J Biol Chem", "key": "B24", "volume": "273", "year": "1998" }, { "DOI": "10.1124/mol.59.4.707", "article-title": "Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states", "author": "Cox", "doi-asserted-by": "publisher", "journal-title": "Mol Pharmacol", "key": "B25", "volume": "59", "year": "2001" }, { "DOI": "10.1186/gb-2003-4-5-p3", "article-title": "DAVID: database for annotation, visualization, and integrated discovery", "author": "Dennis", "doi-asserted-by": "publisher", "first-page": "P3", "journal-title": "Genome Biol", "key": "B26", "volume": "4", "year": "2003" }, { "DOI": "10.1128/mBio.02749-21", "article-title": "CCR2 signaling restricts SARS-coV-2 infection", "author": "Vanderheiden", "doi-asserted-by": "publisher", "journal-title": "mBio", "key": "B27", "volume": "12", "year": "2021" }, { "DOI": "10.1093/cid/ciab717", "article-title": "Clinical spectrum of severe acute respiratory syndrome coronavirus 2 infection and protection from symptomatic reinfection", "author": "Maier", "doi-asserted-by": "publisher", "journal-title": "Clin Infect Dis", "key": "B28", "volume": "75", "year": "2022" }, { "DOI": "10.4269/ajtmh.20-0762", "article-title": "Evaluation of K18-hACE2 mice as a model of SARS-coV-2 infection", "author": "Moreau", "doi-asserted-by": "publisher", "journal-title": "Am J Trop Med Hyg", "key": "B29", "volume": "103", "year": "2020" }, { "DOI": "10.1172/jci.insight.151571", "article-title": "CD8+PD-L1+CXCR3+ polyfunctional T cell abundances are associated with survival in critical SARS-CoV-2–infected patients", "author": "Adam", "doi-asserted-by": "publisher", "journal-title": "JCI Insight", "key": "B30", "volume": "6", "year": "2021" }, { "DOI": "10.1038/s41467-022-34638-2", "article-title": "Immune phenotypes that are associated with subsequent COVID-19 severity inferred from post-recovery samples", "author": "Liechti", "doi-asserted-by": "publisher", "first-page": "7255", "journal-title": "Nat Commun", "key": "B31", "volume": "13", "year": "2022" }, { "DOI": "10.1038/s41392-021-00734-w", "article-title": "Pro-inflammatory microenvironment and systemic accumulation of CXCR3+ cell exacerbate lung pathology of old rhesus macaques infected with SARS-CoV-2", "author": "Zheng", "doi-asserted-by": "publisher", "first-page": "328", "journal-title": "Sig Transduct Target Ther", "key": "B32", "volume": "6", "year": "2021" }, { "DOI": "10.1016/j.ajem.2020.12.003", "article-title": "Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality", "author": "Vafadar Moradi", "doi-asserted-by": "publisher", "journal-title": "Am J Emerg Med", "key": "B33", "volume": "40", "year": "2021" }, { "DOI": "10.1186/s12967-020-02374-0", "article-title": "Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage", "author": "Liu", "doi-asserted-by": "publisher", "first-page": "206", "journal-title": "J Transl Med", "key": "B34", "volume": "18", "year": "2020" }, { "DOI": "10.1016/j.ajem.2020.11.058", "article-title": "Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19", "author": "Seyit", "doi-asserted-by": "publisher", "journal-title": "Am J Emerg Med", "key": "B35", "volume": "40", "year": "2021" }, { "DOI": "10.1016/S0140-6736(20)30566-3", "article-title": "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study", "author": "Zhou", "doi-asserted-by": "publisher", "journal-title": "Lancet", "key": "B36", "volume": "395", "year": "2020" }, { "DOI": "10.1016/j.biopha.2021.112419", "article-title": "Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications", "author": "Majidpoor", "doi-asserted-by": "publisher", "journal-title": "Biomedicine Pharmacotherapy", "key": "B37", "volume": "145", "year": "2022" }, { "DOI": "10.1038/s41467-023-39096-y", "article-title": "Vaccine-induced protection against SARS-CoV-2 requires IFN-γ-driven cellular immune response", "author": "Wang", "doi-asserted-by": "publisher", "first-page": "3440", "journal-title": "Nat Commun", "key": "B38", "volume": "14", "year": "2023" }, { "DOI": "10.3389/fimmu.2023.1284148", "article-title": "IFN-γ-mediated control of SARS-CoV-2 infection through nitric oxide", "author": "Silva", "doi-asserted-by": "publisher", "journal-title": "Front Immunol", "key": "B39", "volume": "14", "year": "2023" }, { "DOI": "10.3389/fimmu.2023.1112870", "article-title": "Neutrophilic inflammation promotes SARS-CoV-2 infectivity and augments the inflammatory responses in airway epithelial cells", "author": "Calvert", "doi-asserted-by": "publisher", "journal-title": "Front Immunol", "key": "B40", "volume": "14", "year": "2023" }, { "DOI": "10.1038/s41467-020-16596-9", "article-title": "Durable and controlled depletion of neutrophils in mice", "author": "Boivin", "doi-asserted-by": "publisher", "journal-title": "Nat Commun", "key": "B41", "volume": "11", "year": "2020" }, { "DOI": "10.3389/fimmu.2018.00781", "article-title": "Natural killer cell recruitment to the lung during influenza A virus infection is dependent on CXCR3, CCR5, and virus exposure dose", "author": "Carlin", "doi-asserted-by": "publisher", "journal-title": "Front Immunol", "key": "B42", "volume": "9", "year": "2018" }, { "DOI": "10.1152/ajplung.00430.2005", "article-title": "CXCR3 surface expression in human airway epithelial cells: cell cycle dependence and effect on cell proliferation", "author": "Aksoy", "doi-asserted-by": "publisher", "journal-title": "Am J Physiol Lung Cell Mol Physiol", "key": "B43", "volume": "290", "year": "2006" }, { "DOI": "10.1038/srep45593", "article-title": "CXCR3+ monocytes/macrophages are required for establishment of pulmonary metastases", "author": "Butler", "doi-asserted-by": "publisher", "journal-title": "Sci Rep", "key": "B44", "volume": "7", "year": "2017" }, { "DOI": "10.4049/jimmunol.0902022", "article-title": "CXCR3 directs antigen-specific effector CD4+ T cell migration to the lung during parainfluenza virus infection", "author": "Kohlmeier", "doi-asserted-by": "publisher", "journal-title": "J Immunol", "key": "B45", "volume": "183", "year": "2009" }, { "DOI": "10.1016/j.immuni.2013.09.013", "article-title": "Lung airway-surveilling CXCR3hi memory CD8+ T cells are critical for protection against influenza A virus", "author": "Slütter", "doi-asserted-by": "publisher", "journal-title": "Immunity", "key": "B46", "volume": "39", "year": "2013" }, { "DOI": "10.1084/jem.20102101", "article-title": "Chemokine receptor CXCR3 facilitates CD8+ T cell differentiation into short-lived effector cells leading to memory degeneration", "author": "Kurachi", "doi-asserted-by": "publisher", "journal-title": "J Exp Med", "key": "B47", "volume": "208", "year": "2011" }, { "article-title": "Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients", "author": "Schmielau", "journal-title": "Cancer Res", "key": "B48", "volume": "61", "year": "2001" }, { "DOI": "10.1016/j.jid.2021.01.027", "article-title": "Regulatory T cells prevent neutrophilic infiltration of skin during contact hypersensitivity reactions by strengthening the endothelial barrier", "author": "Ring", "doi-asserted-by": "publisher", "journal-title": "J Invest Dermatol", "key": "B49", "volume": "141", "year": "2021" }, { "DOI": "10.1038/s41467-024-51353-2", "article-title": "Local administration of regulatory T cells promotes tissue healing", "author": "Nayer", "doi-asserted-by": "publisher", "first-page": "7863", "journal-title": "Nat Commun", "key": "B50", "volume": "15", "year": "2024" }, { "DOI": "10.1681/ASN.2015020203", "article-title": "CXCR3+ regulatory T cells control TH1 responses in crescentic GN", "author": "Paust", "doi-asserted-by": "publisher", "journal-title": "JASN", "key": "B51", "volume": "27", "year": "2016" }, { "DOI": "10.1016/j.immuni.2023.06.003", "article-title": "CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8+ T cell antitumor immunity", "author": "Moreno Ayala", "doi-asserted-by": "publisher", "first-page": "1613", "journal-title": "Immunity", "key": "B52", "volume": "56", "year": "2023" }, { "DOI": "10.1038/nm.1929", "article-title": "Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10", "author": "Sun", "doi-asserted-by": "publisher", "journal-title": "Nat Med", "key": "B53", "volume": "15", "year": "2009" }, { "DOI": "10.1073/pnas.2536517100", "article-title": "IL-27 regulates IL-12 responsiveness of naïve CD4+ T cells through Stat1-dependent and -independent mechanisms", "author": "Lucas", "doi-asserted-by": "publisher", "journal-title": "Proc Natl Acad Sci USA", "key": "B54", "volume": "100", "year": "2003" }, { "DOI": "10.1038/s41590-023-01667-y", "article-title": "Selective IL-27 production by intestinal regulatory T cells permits gut-specific regulation of TH17 cell immunity", "author": "Lin", "doi-asserted-by": "publisher", "journal-title": "Nat Immunol", "key": "B55", "volume": "24", "year": "2023" }, { "DOI": "10.1371/journal.ppat.1004110", "article-title": "Timed action of IL-27 protects from immunopathology while preserving defense in influenza", "author": "Liu", "doi-asserted-by": "publisher", "journal-title": "PloS Pathog", "key": "B56", "volume": "10", "year": "2014" }, { "DOI": "10.1093/jleuko/qiae252", "article-title": "Cxcl10 is protective during mouse-adapted SARS-CoV-2 infection", "author": "Majumdar", "doi-asserted-by": "publisher", "journal-title": "J Leukocyte Biol", "key": "B57", "volume": "117", "year": "2025" }, { "DOI": "10.1016/j.cell.2020.09.050", "article-title": "A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice", "author": "Leist", "doi-asserted-by": "publisher", "first-page": "1070", "journal-title": "Cell", "key": "B58", "volume": "183", "year": "2020" }, { "DOI": "10.1186/s13059-014-0550-8", "article-title": "Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2", "author": "Love", "doi-asserted-by": "publisher", "journal-title": "Genome Biol", "key": "B59", "volume": "15", "year": "2014" } ], "reference-count": 59, "references-count": 59, "relation": {}, "resource": { "primary": { "URL": "https://www.frontiersin.org/articles/10.3389/fimmu.2026.1823264/full" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "CXCR3 ameliorates neutrophil-dependent disease severity in SARS-CoV-2 infection by regulating CD4+ T cell recruitment", "type": "journal-article", "update-policy": "https://doi.org/10.3389/crossmark-policy", "volume": "17" }
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit